Medline Inc - Class A (MDLN) Financial Statements

MDLN Financial Data

EBITDA$2.05B

Revenue (TTM)$28.90B

Gross Profit (TTM)$7.45B

Gross Margin—

Operating Margin7.78%

ROE8.89%

ROA2.48%

Debt/Equity1.17

Current Ratio4.29

FCF$1.30B

FCF Yield2.73%

Piotroski F-Score—

Rev/Share (TTM)$22.00

50-Day MA$43.48

200-Day MA—

Shares Outstanding1.31B

MDLN Computed Insights

FCF$1.30B

FCF Growth Rate—

EPS Growth (CAGR)—

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

MDLN Financial Statements & Data

Medline Inc - Class A (MDLN) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Medline Inc - Class A's financial performance and position as a Healthcare company.

Trailing twelve-month (TTM) revenue is $28.90B. Gross profit (TTM) is $7.45B. EBITDA is $2.05B. Earnings per share (EPS) is $-0.01. The P/E ratio is 49.78. Market capitalization is $47.54B.

Free cash flow (FCF) is $1.30B. Weighted average cost of capital (WACC) is 10.00%.

Historical revenue data covers 4 years from FY22 to FY25. Net income history spans 4 years. Free cash flow and capital expenditure data spans 4 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Medline Inc - Class A's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.